n(g),n(g')-dimethyl-l-arginine has been researched along with Angor Pectoris in 13 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the hypothesis that asymmetric dimethylarginine (ADMA) levels could be elevated and influence endothelin-1 and nitric oxide release and action in patients with cardiac syndrome X (CSX)." | 9.10 | Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. ( Chierchia, S; Fermo, I; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Paroni, R; Piatti, P; Pozza, G; Setola, E, 2003) |
| "To monitor the changes of plasma asymmetric dimethylarginine (ADMA), nitric oxide (NO), and von Willebrand factor (vWF) levels in patients with stable angina pectoris (SAP) or acute coronary syndrome (ACS) and to evaluate the correlation between ADMA and different types of coronary heart disease." | 7.76 | Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease. ( Cao, Y; Ouyang, M; Xiao, L; Yang, K; Zhang, Z, 2010) |
| "We tested the hypothesis that asymmetric dimethylarginine (ADMA) levels could be elevated and influence endothelin-1 and nitric oxide release and action in patients with cardiac syndrome X (CSX)." | 5.10 | Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. ( Chierchia, S; Fermo, I; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Paroni, R; Piatti, P; Pozza, G; Setola, E, 2003) |
| "To monitor the changes of plasma asymmetric dimethylarginine (ADMA), nitric oxide (NO), and von Willebrand factor (vWF) levels in patients with stable angina pectoris (SAP) or acute coronary syndrome (ACS) and to evaluate the correlation between ADMA and different types of coronary heart disease." | 3.76 | Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease. ( Cao, Y; Ouyang, M; Xiao, L; Yang, K; Zhang, Z, 2010) |
| "Given that the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, can decrease nitric oxide bioavailability and lead to atherosclerosis, its concentration can be a good predictor for coronary artery disease." | 3.73 | Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography. ( Biberoglu, G; Cengel, A; Hasanoglu, A; Sahinarslan, A; Timurkaynak, T; Turkoglu, S, 2006) |
| "G-CSF therapy induced leukocytosis and a rise in CD34+ cell levels." | 2.75 | The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA. ( Bode-Böger, SM; Goette, A; Jentsch-Ullrich, K; Lendeckel, U; Martens-Lobenhoffer, J; Scalera, F; Wolfram, O, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Parikh, RV | 1 |
| Pargaonkar, V | 1 |
| Ball, RL | 1 |
| Kobayashi, Y | 1 |
| Kimura, T | 1 |
| Yeung, AC | 1 |
| Cooke, JP | 1 |
| Tremmel, JA | 1 |
| Günebakmaz, O | 1 |
| Duran, M | 1 |
| Karakaya, E | 1 |
| Tanrıkulu, E | 1 |
| Akpek, M | 1 |
| Ergin, A | 1 |
| Kaya, MG | 1 |
| Jiang, DJ | 1 |
| Cao, Y | 2 |
| Xin, HY | 1 |
| Li, XH | 1 |
| Luo, ZQ | 1 |
| Li, YJ | 1 |
| Goette, A | 1 |
| Wolfram, O | 1 |
| Jentsch-Ullrich, K | 1 |
| Martens-Lobenhoffer, J | 1 |
| Scalera, F | 1 |
| Lendeckel, U | 1 |
| Bode-Böger, SM | 2 |
| Surdacki, A | 1 |
| Marewicz, E | 1 |
| Wieczorek-Surdacka, E | 1 |
| Rakowski, T | 1 |
| Szastak, G | 1 |
| Pryjma, J | 1 |
| Dudek, D | 1 |
| Dubiel, JS | 1 |
| Yang, K | 1 |
| Zhang, Z | 1 |
| Ouyang, M | 1 |
| Xiao, L | 1 |
| Closs, EI | 1 |
| Ostad, MA | 1 |
| Simon, A | 1 |
| Warnholtz, A | 1 |
| Jabs, A | 1 |
| Habermeier, A | 1 |
| Daiber, A | 1 |
| Förstermann, U | 1 |
| Münzel, T | 1 |
| Piatti, P | 1 |
| Fragasso, G | 1 |
| Monti, LD | 1 |
| Setola, E | 1 |
| Lucotti, P | 1 |
| Fermo, I | 1 |
| Paroni, R | 1 |
| Galluccio, E | 1 |
| Pozza, G | 1 |
| Chierchia, S | 1 |
| Margonato, A | 1 |
| Hori, T | 1 |
| Matsubara, T | 1 |
| Ishibashi, T | 1 |
| Ozaki, K | 1 |
| Tsuchida, K | 1 |
| Mezaki, T | 1 |
| Tanaka, T | 1 |
| Nasuno, A | 1 |
| Kubota, K | 1 |
| Nakamura, Y | 1 |
| Yamazoe, M | 1 |
| Aizawa, Y | 1 |
| Nishio, M | 1 |
| Lu, TM | 1 |
| Ding, YA | 1 |
| Lin, SJ | 1 |
| Lee, WS | 1 |
| Tai, HC | 1 |
| Valkonen, VP | 1 |
| Laaksonen, R | 1 |
| Sahinarslan, A | 1 |
| Cengel, A | 1 |
| Biberoglu, G | 1 |
| Hasanoglu, A | 1 |
| Turkoglu, S | 1 |
| Timurkaynak, T | 1 |
| Walker, HA | 1 |
| McGing, E | 1 |
| Fisher, I | 1 |
| Böger, RH | 1 |
| Jackson, G | 1 |
| Ritter, JM | 1 |
| Chowienczyk, PJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sex Differences in Symptomatic Non-Obstructive Coronary Disease: Do Women Have a Unique Coronary Pathophysiology?[NCT00823563] | 126 participants (Anticipated) | Observational | 2007-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for n(g),n(g')-dimethyl-l-arginine and Angor Pectoris
| Article | Year |
|---|---|
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; St | 2004 |
3 trials available for n(g),n(g')-dimethyl-l-arginine and Angor Pectoris
| Article | Year |
|---|---|
The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Antioxidants; Arginine; Cells, Cultured; Chromans; Coronar | 2010 |
Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
Topics: Angina Pectoris; Arginine; Blood Pressure; Coronary Angiography; Cyclic GMP; Endothelin-1; Endotheli | 2003 |
Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance.
Topics: Administration, Oral; Angina Pectoris; Arginine; Dinoprost; Double-Blind Method; Endothelium, Vascul | 2001 |
9 other studies available for n(g),n(g')-dimethyl-l-arginine and Angor Pectoris
| Article | Year |
|---|---|
Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
Topics: Angina Pectoris; Arginine; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vesse | 2020 |
Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy.
Topics: Aged; Angina Pectoris; Arginine; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; K | 2013 |
Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Arginine; Blood Coagulation; Case-Control Studies; C | 2009 |
Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antigens, CD34; Arginine; Biomarkers; | 2010 |
Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Arginine; Biomarkers; Coronary Disease; Female; Huma | 2010 |
Impairment of the extrusion transporter for asymmetric dimethyl-L-arginine: a novel mechanism underlying vasospastic angina.
Topics: Adult; Angina Pectoris; Arginine; Blood Platelets; Coronary Vasospasm; Endothelium, Vascular; Enzyme | 2012 |
Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina.
Topics: Aged; Angina Pectoris; Arginine; Case-Control Studies; Coronary Angiography; Coronary Circulation; C | 2003 |
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pr | 2003 |
Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Arginine; Coronary Angiography; Coronary Artery Disease; F | 2006 |